Source: Breathe 2008; 5: 163-167



Rating:

Share or cite this content

Citations should be made in the following way:
J.C. Davies. The cystic fibrosis transmembrane conductance regulator: state of the art. Breathe 2008; 5: 163-167

Member's Comments

No comment yet.

Related content which might interest you: The cystic fibrosis transmembrane conductance regulator and its modulators: clinical implications Source: Virtual Congress 2020 – Respiratory infections Year: 2020 Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis Source: Eur Respir Rev 2013; 22: 58-65 Year: 2013 Cystic fibrosis transmembrane conductance regulator pharmacotherapy Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88 Year: 2006 A three miRNA signature regulates the CF transmembrane conductance regulator (CFTR) in cystic fibrosis airway epithelium Source: Annual Congress 2011 - Epithelial cells: role in health and disease Year: 2011 Atypical cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38 Year: 2006 Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator (CFTR) ion transport Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient Source: Eur Respir J 2002; 19: 374-376 Year: 2002 How organoids helped to discover cystic fibrosis transmembrane conductance regulator (CFTR) therapeutics and predict response to treatment Source: International Congress 2016 – Closing the gap: novel translational research strategies Year: 2016 Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID) Source: Breathe, 17 (3) 210088; 10.1183/20734735.0088-2021 Year: 2021 Channelopathies in bronchiectasis Source: Eur Respir Mon 2011; 52: 150-162 Year: 2011 Expression and function of cystic fibrosis transmembrane conductance regulator in rat intrapulmonary arteries Source: Eur Respir J 2007; 30: 857-864 Year: 2007 CFTR: cystic fibrosis and beyond Source: Eur Respir J 2014; 44: 1042-1054 Year: 2014 Cross-talk of inflammatory mediators and airway epithelium reveals the cystic fibrosis transmembrane conductance regulator as a major target Source: ERJ Open Res, 7 (4) 00247-2021; 10.1183/23120541.00247-2021 Year: 2021 Association of residual function of cystic fibrosis transmembrane conductance regulator and lung clearance index in patients with normal FEV1 Source: International Congress 2017 – Assessing the impact of respiratory and sleep problems in children Year: 2017 LATE-BREAKING ABSTRACT: Reducing inflammation in the lung by targeting the endothelial cystic fibrosis transmembrane conductance regulator with copper-tobramycin Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Pharmacology and regulation of ENaC function: implication in cystic fibrosis Source: Annual Congress 2009 - Novel regulators of alveolar liquid clearance Year: 2009 An assay of CF transmembrane conductance regulator function that uses primary CF intestinal organoids: shared experiences with the Russian CF centre Source: International Congress 2018 – Russian Speaking Programme 2018: Part I Year: 2018 ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies Source: Eur Respir J, 56 (6) 2000946; 10.1183/13993003.00946-2020 Year: 2020 Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function Source: Eur Respir J 2011; 37: 1076-1082 Year: 2011 Cystic fibrosis: to ion transport and beyond Source: Eur Respir J 2010; 36: 991-992 Year: 2010